Top Ten IPOs in past 12 Months
These outperformers have shown stellar performance after their IPOs, all within the past 12 months. Six out of ten of these IPOs are from the United States. Four are from California.
#1 Up 375.06% since September 26, 2017 IPO - TDH Holding - PETZ
Shandong Province People’s Republic of China
Share Price at today's close $15.89
Premier producers of high quality pet food for China and worldwide.
#2 Up 343.33% since January 26, 2017 IPO - AnaptysBio - ANAB
San Diego, California, USA
Share Price at today's close $71.23
A biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation and immuno-oncology.
Ra'anana, Israel
Share price at today's close $43.26
We are a clinical stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies.
#4 Up 210.89% since December 9, 2016 IPO - Ichor Holding, Ltd. - ICHR
Fremont, California, USA
Share price at today's close $28.98
We are a leader in the design, engineering and manufacturing of critical fluid delivery subsystems for semiconductor capital equipment.
#5 Up 168.64% since May 24, 2017 IPO - SMART Global Holdings - SGH
Newark, California, USA
Share price at today's close $29.51
We are a global leader in specialty memory solutions, serving the electronics industry for over 25 years.
New Brighton, MN 55112
Share price at today's close $21.16
By combining our leading gene-editing technology and technical expertise with our innovative commercial strategy, we are pioneering a paradigm shift to deliver healthier food ingredients for consumers and agriculturally advantageous traits for farmers.
Yantai City, Shandong Province People’s Republic of China
Share price at today's close $13.93
We are a wastewater purification treatment company that focuses on the development, manufacture and sale of DTRO and DTNF membrane filtration products that are used in the treatment, recycling and discharge of wastewater.
*web address not available
#8 Up 140.25% since July 14, 2017 IPO - Akcea Therapeutics - AKCA
Cambridge, Massachusetts, USA
Share price at today's close $17.58
We are a late stage biopharmaceutical company focused on developing and commercializing drugs to treat patients with serious cardiometabolic diseases caused by lipid disorders.
Los Gatos, California, USA
Share price at today's close $42.71
We pioneered streaming to the TV. Roku connects users to the streaming content they love, enables content publishers to build and monetize large audiences and provides advertisers with unique capabilities to engage consumers.
Minneapolis, Minnesota, USA
Share price at today's close $21.00
We are a cellular analysis company that is discovering new cancer sub-types and commercializing diagnostic tests designed to significantly improve the clinical outcomes of cancer patients treated with targeted therapies.
Understanding our economic influences helps me be a better agent for you.
There's nothing quite like being completely satisfied.
Deniece Smith - "got agent?" 650-483-2055
Information from IPOScoop.com
header.all-comments